newsfilter
← Latest News
GlobeNewswire·

Angion Provides Corporate Update and Reports First Quarter 2022 Financial Results

-- Ended the quarter with $73M in cash and cash equivalents sufficient to fund operations well into 2023 UNIONDALE, N.Y., May 16, 2022 (GLOBE NEWSWIRE) -- Angion Biomedica Corp (NASDAQ:ANGN), a biopharmaceutical company focused on the discovery, dev